Bupivacaine Completed Phase 1 Trials for Pain, Acute Basic Science

IndicationsStatusPurposePhase
CompletedBasic Science1
clinicaltrials.gov IdentifierTitleDrugs
NCT02982889Single Ascending Dose Study of Two Liquidia Bupivacaine Formulations